Literature DB >> 27715388

Medical Malpractice in Uveitis: A Review of Clinical Entities and Outcomes.

Ashvini K Reddy1, Stephanie B Engelhard2, Christopher T Shah2, Austin J Sim3, Jennifer E Thorne1,4.   

Abstract

PURPOSE: To guide risk management in uveitis.
METHODS: Retrospective review of malpractice verdicts, rulings, and settlements.
RESULTS: The WestLaw® database was reviewed for lawsuits related to uveitis in the United States from 1930-2014. Twenty-five cases met inclusion criteria, and 48% of these were infectious. Overall, 64% of outcomes favored the defendant ophthalmologist. The most common diagnoses were viral retinitis (28%), iritis (12%), syphilis (8%), and toxoplasmosis (8%). Seven suits (28%) were resolved by settlement, with mean adjusted indemnities of $724,302 (median, $409,390; range, $127,837-2,021,887). Two cases (8%) resulted in plaintiff verdict, with adjusted awards of $1,399,800 and $630,799.
CONCLUSIONS: Despite being a rare diagnosis, viral retinitis (especially acute retinal necrosis) is the most common clinical entity associated with litigation in uveitis and should be considered early. Educating patients about potential adverse events, early testing for syphilis, and maintaining a positive relationship may also minimize risk.

Entities:  

Keywords:  Acute retinal necrosis; litigation; malpractice; uveitis

Mesh:

Year:  2016        PMID: 27715388     DOI: 10.1080/09273948.2016.1202289

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  5 in total

1.  Malpractice Litigation in Ophthalmic Trauma.

Authors:  Stephanie B Engelhard; Sherveen S Salek; Grant A Justin; Austin J Sim; Fasika A Woreta; Ashvini K Reddy
Journal:  Clin Ophthalmol       Date:  2020-07-12

2.  Malpractice Litigation in Ocular Oncology.

Authors:  Stephanie B Engelhard; Mary E Aronow; Christopher T Shah; Austin J Sim; Ashvini K Reddy
Journal:  Ocul Oncol Pathol       Date:  2017-09-30

3.  Improving the rates of electronic results acknowledgement at a tertiary eye care centre.

Authors:  Val Phua; Benjamin Au; Yu Qiang Soh; Rahat Husain
Journal:  BMJ Open Qual       Date:  2017-10-18

4.  High drug payload nanoparticles formed from dexamethasone-peptide conjugates for the treatment of endotoxin-induced uveitis in rabbit.

Authors:  Xinxin Yu; Renshu Zhang; Lei Lei; Qianqian Song; Xingyi Li
Journal:  Int J Nanomedicine       Date:  2019-01-14

5.  SARI prevents ocular angiogenesis and inflammation in mice.

Authors:  Wenqiu Zhang; Lei Dai; Xun Li; Yiming Li; Maurice Keng Hung Yap; Longqian Liu; Hongxin Deng
Journal:  J Cell Mol Med       Date:  2020-03-02       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.